HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Late Sac Behavior after Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm.

AbstractBACKGROUND:
Sac behavior after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) is considered as a surrogate for the risk of late rupture. The purpose of the study is to assess the sac behavior of AAAs after EVAR.
METHODS AND RESULTS:
Late sac enlargement (LSE) (≥5 mm) and late sac shrinkage (LSS) (≥5 mm) were analyzed in 589 consecutive patients who were registered at 14 national centers in Japan. The proportions of patients who had LSE at 1, 3 and 5 years were 2.6% ± 0.7%, 10.0% ± 1.6% and 19.0% ± 2.9%. The proportions of patients who had LSS at 1, 3 and 5 years were 50.1% ± 0.7%, 59.2% ± 2.3% and 61.7% ± 2.7%. Multiple logistic regression analysis identified two variables as a risk factor for LSE; persistent endoleak (Odds ratio 9.56 (4.84-19.49), P <0.001) and low platelet count (Odds ratio 0.92 (0.86-0.99), P = 0.0224). The leading cause of endoleak in patients with LSE was type II.
CONCLUSIONS:
The incidence of LSE is not negligible over 5 year period. Patients with persistent endoleak and/or low platelet count should carefully be observed for LSE.
CLINICAL TRIAL REGISTRATION:
UMIN-CTR (UMIN000008345).
AuthorsMasahiro Okada, Nobuhiro Handa, Toshihiro Onohara, Minoru Okamoto, Tsuyoshi Yamamoto, Yasushi Shimoe, Masafumi Yamashita, Toshiki Takahashi, Jyunji Kishimoto, Akihiro Mizuno, Junichi Kei, Mikizou Nakai, Masayuki Sakaki, Hitoshi Suhara, Fuminori Kasashima, Masamitsu Endo, Takeshi Nishina, Tadashi Furuyama, Masakazu Kawasaki, Keiji Iwata, Akira Marumoto, Yasuhisa Urata, Katsutoshi Sato, Masahiro Ryugo, National Hospital Organization Network Study Group for Abdominal Aortic Aneurysm in Japan
JournalAnnals of vascular diseases (Ann Vasc Dis) Vol. 9 Issue 2 Pg. 102-7 ( 2016) ISSN: 1881-641X [Print] Japan
PMID27375803 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: